Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways
about
The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancerRedox-directed cancer therapeutics: molecular mechanisms and opportunitiesSensitivity and fidelity of DNA microarray improved with integration of Amplified Differential Gene Expression (ADGE)S-glutathionylation: from molecular mechanisms to health outcomesCharacterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytesRelationships between metabolic and non-metabolic susceptibility factors in benzene toxicity.Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosisS-glutathionylated serine proteinase inhibitors as plasma biomarkers in assessing response to redox-modulating drugsGlutathione S-transferase P influences redox and migration pathways in bone marrow.THE GSTP1 c.313A>G POLYMORPHISM MODULATES THE CARDIORESPIRATORY RESPONSE TO AEROBIC TRAINING.Low levels of GSTA1 expression are required for Caco-2 cell proliferation.Redox platforms in cancer drug discovery and development.Oral ezatiostat HCl (Telintra®, TLK199) and idiopathic chronic neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor.Oxidative stress, redox regulation and diseases of cellular differentiation.Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.Glutathione S-transferase P1-1 expression modulates sensitivity of human kidney 293 cells to photodynamic therapy with hypericin.NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance.Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxificationGlutathione-s-transferases as determinants of cell survival and death.Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patientsGSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling.Glutathione S-transferase pi modulates NF-κB activation and pro-inflammatory responses in lung epithelial cells.Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer.Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress.Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π.Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity.The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganismPhase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.Pleiotropic functions of glutathione S-transferase PMarkedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione S-transferase Pi.The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies.Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.Glutathione S-Transferase P-Mediated Protein S-Glutathionylation of Resident Endoplasmic Reticulum Proteins Influences Sensitivity to Drug-Induced Unfolded Protein Response.Effect of a glutathione S-transferase inhibitor on oxidative stress and ischemia-reperfusion-induced apoptotic signalling of cultured cardiomyocytes.Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: a case report of sustained hematologic response following an abbreviated exposure.Pharmacology of a mimetic of glutathione disulfide, NOV-002.Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function.Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice.MGST1, a GSH transferase/peroxidase essential for development and hematopoietic stem cell differentiation.NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL-6/STAT3 signaling
P2860
Q24603861-5CCC73B9-8214-4C72-AF4F-1DF8052FCCA2Q24645584-1625A77F-B17C-4FD6-AB32-CC9191F98EDDQ24793538-562EBF5E-1050-430F-BBF4-83085762F32FQ30398587-67F3E879-9139-4EF9-A40F-BB164DC20C8DQ31119257-55737A22-3FE2-4F8C-A532-46AE132BCBF4Q33756205-3228D1F0-035D-4711-96F6-5644BE65F53EQ33909418-62F95A60-E8CF-45D3-838F-8A0040A1DFEFQ34117297-C0E0A80A-6495-4359-ADBF-9BC4214A2634Q34172593-47FCDB91-2F2A-49B2-9041-CEDCA255F65FQ34374468-E0458D4C-3A26-4EC3-A0F7-087997009B31Q34517167-BAFE26D9-1963-480D-9D4E-52340D1427DBQ34777711-922FC209-F53D-452E-A12F-259BFFB16162Q35607713-AB2F9EDA-254F-4D59-BB6F-D882CFAD8F5DQ35611511-30A05351-2E6A-49DD-8425-AE7698B608C3Q35615943-D7E2DE86-D778-4AA8-953A-B3E68AA852B4Q35624542-6453F2BE-1B12-4E75-8779-656029065847Q36095837-8A48ADE6-768E-429A-817F-B470016FEB35Q36155865-02E0F32B-C7E0-470B-9E9E-22E97B88494FQ36326547-E65E31FD-B74A-4595-99A7-CA6D26AC4391Q36613823-B54495EC-8EEA-4AAF-98B9-72087734C18BQ36621556-8BB2FBF6-24C6-454D-8611-DEE2CBB9E072Q36787561-12C6DC39-DE8D-4551-BED9-A6D781A9E062Q36972046-E61D5E2E-08BE-465E-9583-2FA39C7FD0F0Q37029859-917A27E1-87BF-4E64-BA2A-EDA6AA12176EQ37041521-B31DE9D5-8F02-4B9B-8F9C-48FA02A7667EQ37155362-EC6FB91D-85E6-4B87-812B-95D261D299E7Q37172089-7861FDC3-238A-4457-9A73-D54101CDDCABQ37222119-C6E59C32-DA7B-400C-A987-70C669007699Q37364876-3F7B0342-12EE-4FBE-9087-A3D215890FCDQ37420626-EF1FFF31-1931-4013-9360-D845864FAFA6Q37800633-D518C59A-5ABC-4E13-AABF-3B894656B5DAQ38777221-11455FA0-FC61-4E99-9869-2CE6E30D3AE6Q38797228-EB477941-FEDB-472D-BF22-56F73B27450AQ38963762-E742921B-0E82-4A5F-85F6-DFED89E868B9Q40648327-F7AE8DF9-C537-4386-9A77-5D5463625A96Q41956100-B2E527D7-11E0-4F40-94FC-081AFD33D9E5Q42048712-7D6CF65A-CFB7-4268-86B2-5D1D7FBCBA98Q51765947-763EA8B5-0388-4678-96B9-234B645CBB4EQ52558567-AF85D27F-36C2-4C83-BFA8-9B8A96E0565DQ58130121-92564F74-F90B-49CC-916A-2160987B4C0E
P2860
Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Pharmacologic or genetic manip ...... es cell proliferation pathways
@ast
Pharmacologic or genetic manip ...... es cell proliferation pathways
@en
Pharmacologic or genetic manip ...... es cell proliferation pathways
@en-gb
Pharmacologic or genetic manip ...... es cell proliferation pathways
@nl
type
label
Pharmacologic or genetic manip ...... es cell proliferation pathways
@ast
Pharmacologic or genetic manip ...... es cell proliferation pathways
@en
Pharmacologic or genetic manip ...... es cell proliferation pathways
@en-gb
Pharmacologic or genetic manip ...... es cell proliferation pathways
@nl
prefLabel
Pharmacologic or genetic manip ...... es cell proliferation pathways
@ast
Pharmacologic or genetic manip ...... es cell proliferation pathways
@en
Pharmacologic or genetic manip ...... es cell proliferation pathways
@en-gb
Pharmacologic or genetic manip ...... es cell proliferation pathways
@nl
P2093
P921
P3181
P1476
Pharmacologic or genetic manip ...... es cell proliferation pathways
@en
P2093
C J Henderson
J E Ruscoe
L A Rosario
P Arifoglu
P304
P3181
P407
P577
2001-07-01T00:00:00Z